MANILA, Dec 12 (Xinhua): AstraZeneca, the Britain-based drug maker, has withdrawn its application to conduct Covid-19 vaccine clinical trials in the Philippines, the country's Food and Drug Administration (FDA) has announced.
"They (AstraZeneca) said they have enough data already," Enrique Domingo, the FDA director general, said in a text message to Xinhua, explaining the reason AstraZeneca cited for withdrawing trials application.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!